Summary

10% of patients with hypertension potentially have the treatable condition – primary aldosteronism. Primary aldosteronism (PA) is caused by either bilateral adrenal disease(~40%), managed with lifelong medications; or unilateral disease (~60%), cured with laparoscopic surgery (adrenalectomy). Unfortunately, many patients with curable hypertensionremain undiagnosed and consequently develop cardiac disease and strokes. The difficulty with identifying curable unilateral disease is due to adrenal vein sampling (AVS): an invasive,and technically-difficult procedure, with inconclusive results in 50% of patients. An Alternative novel imaging, 11C-metomidate Positron emission tomography-computed tomography(PET-CT), can detect adrenal tumors, and concurrently confirm their over-activity. It is non-invasive, non-operator-dependent, and can identify more patients with incurable hypertension.Investigators hypothesize that 11C-metomidate PET-CT can accurately identify patients with surgically-curable unilateral adrenal disease among hypertensive Asians with primary aldosteronism.

Study Name: Primary Aldosteronism and Surgically Curable Forms in Hypertension Patients Using 11C-Metomidate
Status: Active
Conditions: Primary aldosteronism
Interventions: Combination Product: 11C-Metomidate PET/CT Scan
Locations: Changi General Hospital, Singapore, Singapore
Study link: https://ClinicalTrials.gov/show/NCT03990701

To search for other studies by topic, location, or status, go to our Clinical Studies page.

©2021 Primary Aldosteronism Foundation — All Rights Reserved

The Primary Aldosteronism Foundation is a registered 501(c)(3) public charity. Donations are tax deductible in the US.

©2021 Primary Aldosteronism Foundation

The Primary Aldosteronism Foundation is a registered 501(c)(3) public charity. Donations are tax deductible in the US.